These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24005254)

  • 21. Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.
    Hoang JD; Salavatian S; Yamaguchi N; Swid MA; David H; Vaseghi M
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32493842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galanin modulates cholinergic neurotransmission in the heart.
    Potter EK; Smith-White MA
    Neuropeptides; 2005 Jun; 39(3):345-8. PubMed ID: 15944033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β-adrenergic receptors.
    van Weperen VYH; Hoang JD; Jani NR; Khaky A; Herring N; Smith C; Vaseghi M
    J Physiol; 2024 Feb; ():. PubMed ID: 38352977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY.
    Mundinger TO; Taborsky GJ
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
    Serone AP; Wright CE; Angus JA
    Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats.
    Zukowska-Grojec Z; Golczynska M; Shen GH; Torres-Duarte A; Haass M; Wahlestedt C; Myers AK
    Pediatr Nephrol; 1993 Dec; 7(6):845-52. PubMed ID: 7907499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications.
    Benarroch EE
    Ann Neurol; 1994 Jul; 36(1):6-13. PubMed ID: 8024263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States.
    Larsen HE; Bardsley EN; Lefkimmiatis K; Paterson DJ
    J Neurosci; 2016 Aug; 36(33):8562-73. PubMed ID: 27535905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat.
    Shanks J; Mane S; Ryan R; Paterson DJ
    Hypertension; 2013 Jan; 61(1):187-93. PubMed ID: 23172922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter.
    Parrish DC; Gritman K; Van Winkle DM; Woodward WR; Bader M; Habecker BA
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H99-H106. PubMed ID: 17951370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension.
    Lu CJ; Hao G; Nikiforova N; Larsen HE; Liu K; Crabtree MJ; Li D; Herring N; Paterson DJ
    Hypertension; 2015 Jun; 65(6):1288-1297. PubMed ID: 25916729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.
    Byku M; Macarthur H; Westfall TC
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H457-65. PubMed ID: 19933420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
    Esler M; Kaye D
    Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
    Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of release and function of neuropeptides in the heart.
    Archelos J; Xiang JZ; Reinecke M; Lang RE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S45-50. PubMed ID: 2455192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training improves hypertension-induced autonomic dysfunction without influencing properties of peripheral cardiac vagus nerve.
    Neto OB; de Sordi CC; da Mota GR; Marocolo M; Chriguer RS; da Silva VJD
    Auton Neurosci; 2017 Dec; 208():66-72. PubMed ID: 28964689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.